Axsome Therapeutics (AXSM) Misses Q1 EPS by 93c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.03), $0.93 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI